In a statement, the CEO of Arcturus Therapeutics Holdings Inc disclosed, the U.S.-based company is in discussions with around a dozen countries for a COVID-19 vaccine supply agreement. The company is in early human testing of its COVID-19 candidate. In… Read More ›
Drugmakers, including Gilead Sciences Inc, Bristol-Myers Squibb Co, and Biogen Inc have hiked their U.S. list prices on more than 50 drugs, according to data analyzed by 3 Axis Advisors, a healthcare research firm. On Tuesday, there were media reports… Read More ›
The deal will not only add to Pfizer’s EPS, but will also provide to stronger traction in the cancer drugs market. U.S. pharmaceutical giant Pfizer Inc stated it would acquire Array Biopharma Inc for $10.64 billion in cash. The potential… Read More ›
The strategic development places the Ian Read as its chairman and opens up the CEO post which could be filled at a later date. Under Read’s steady stewardship, Pfizer Inc’s stock has gone up by 160% since December 2010. Pfizer… Read More ›
With Reckitt Benckiser out of the race, it is advantage GlaxoSmithKline Plc. Reckitt Benckiser Group, a British consumer goods group, has withdrawn from discussions with Pfizer Inc over buying its consumer healthcare business. According to sources familiar with the matter… Read More ›
manageria.biz 